» Articles » PMID: 36872645

Progressive Grey Matter Alterations in Bipolar Disorder Across the Life Span - A Systematic Review

Overview
Journal Bipolar Disord
Specialty Psychiatry
Date 2023 Mar 6
PMID 36872645
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To elucidate the relationship between the course of bipolar disorder (BD) and structural brain changes across the life span, we conducted a systematic review of longitudinal imaging studies in adolescent and adult BD patients.

Methods: Eleven studies with 329 BD patients and 277 controls met our PICOS criteria (participants, intervention, comparison, outcome and study design): BD diagnosis based on DSM criteria, natural course of disease, comparison of grey matter changes in BD individuals over ≥1-year interval between scans.

Results: The selected studies yielded heterogeneous findings, partly due to varying patient characteristics, data acquisition and statistical models. Mood episodes were associated with greater grey matter loss in frontal brain regions over time. Brain volume decreased or remained stable in adolescent patients, whereas it increased in healthy adolescents. Adult BD patients showed increased cortical thinning and brain structural decline. In particular, disease onset in adolescence was associated with amygdala volume reduction, which was not reported in adult BD.

Conclusions: The evidence collected suggests that the progression of BD impairs adolescent brain development and accelerates structural brain decline across the lifespan. Age-specific changes in amygdala volume in adolescent BD suggest that reduced amygdala volume is a correlate of early onset BD. Clarifying the role of BD in brain development across the lifespan promises a deeper understanding of the progression of BD patients through different developmental episodes.

Citing Articles

[Long-term courses of bipolar disorders].

Czempiel T, Mikolas P, Bauer M, Vogel S, Ritter P Nervenarzt. 2024; 96(1):15-22.

PMID: 39709326 PMC: 11772376. DOI: 10.1007/s00115-024-01791-6.


Cerebrospinal Fluid Biomarkers of Central Nervous System Inflammation Predict Cortical Decline in Bipolar Disorder and Ventricular Enlargement in Healthy Controls.

Bellaagh Johansson T, Klahn A, Goteson A, Abe C, Sellgren C, Landen M Neuropsychobiology. 2024; 84(1):38-47.

PMID: 39626639 PMC: 11797920. DOI: 10.1159/000542888.


Alterations of subcortical structure volume in pediatric bipolar disorder patients with manic or depressive first-episode.

Gao W, Chen Y, Cui D, Zhu C, Jiao Q, Su L BMC Psychiatry. 2024; 24(1):762.

PMID: 39487398 PMC: 11531125. DOI: 10.1186/s12888-024-06208-x.


Early use of long-acting injectable antipsychotics in bipolar disorder type I: An expert consensus.

Vieta E, Tohen M, McIntosh D, Kessing L, Sajatovic M, McIntyre R Bipolar Disord. 2024; 27(1):7-16.

PMID: 39438154 PMC: 11848019. DOI: 10.1111/bdi.13498.


Innovative Neuroimaging Biomarker Distinction of Major Depressive Disorder and Bipolar Disorder through Structural Connectome Analysis and Machine Learning Models.

Huang Y, Zhang J, He K, Mo X, Yu R, Min J Diagnostics (Basel). 2024; 14(4).

PMID: 38396428 PMC: 10888009. DOI: 10.3390/diagnostics14040389.